-
Intuitive Surgical Inc. (ISRG $469.81)
-
AbbVie Inc. (ABBV $198.86)
-
Bristol-Myers Squibb Company (BMY $45.36)
-
CVS Health Corporation (CVS $63.58)
-
Merck & Company Inc. (MRK $80.37)
-
GSK plc American Depositary Shares (Each representing two) (GSK $37.58)
Q: As a new subscriber, I’m thoroughly impressed with your advice and 5i Research services overall - thank you for all that you do.
I currently hold ABBV, BMY, CVS, and GSK in a long-term hold, diversified RRSP portfolio. I’m not necessarily looking to add further healthcare exposure, but am very interested in the long term prospects for MRK +/- ISRG and would appreciate your opinion on them. And compared to my existing companies, would there be a suggested ranking of these six in terms of potential for long term compounding growth?
I currently hold ABBV, BMY, CVS, and GSK in a long-term hold, diversified RRSP portfolio. I’m not necessarily looking to add further healthcare exposure, but am very interested in the long term prospects for MRK +/- ISRG and would appreciate your opinion on them. And compared to my existing companies, would there be a suggested ranking of these six in terms of potential for long term compounding growth?